Disease Modeling of Mitochondrial Cardiomyopathy Using Patient-Specific Induced Pluripotent Stem Cells.
Takeshi TokuyamaRazan Elfadil AhmedNawin ChanthraTatsuya AnzaiHideki UosakiPublished in: Biology (2021)
Mitochondrial cardiomyopathy (MCM) is characterized as an oxidative phosphorylation disorder of the heart. More than 100 genetic variants in nuclear or mitochondrial DNA have been associated with MCM. However, the underlying molecular mechanisms linking genetic variants to MCM are not fully understood due to the lack of appropriate cellular and animal models. Patient-specific induced pluripotent stem cell (iPSC)-derived cardiomyocytes (iPSC-CMs) provide an attractive experimental platform for modeling cardiovascular diseases and predicting drug efficacy to such diseases. Here we introduce the pathological and therapeutic studies of MCM using iPSC-CMs and discuss the questions and latest strategies for research using iPSC-CMs.
Keyphrases
- induced pluripotent stem cells
- mitochondrial dna
- stem cells
- heart failure
- copy number
- oxidative stress
- cardiovascular disease
- high glucose
- diabetic rats
- high throughput
- emergency department
- atrial fibrillation
- endothelial cells
- type diabetes
- metabolic syndrome
- coronary artery disease
- mesenchymal stem cells
- cell therapy
- adverse drug